{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:38:07Z","timestamp":1792550287137,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00504","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T07:41:06Z","timestamp":1557819666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Antibiotic Class and Outcome in Post-stroke Infections: An Individual Participant Data Pooled Analysis of VISTA-Acute"],"prefix":"10.3389","volume":"10","author":[{"given":"Craig J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Heal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Vail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Jeans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willeke F.","family":"Westendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Nederkoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"van de Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1212\/WNL.0b013e31823152b1","article-title":"On behalf of the Investigators of the Registry of the Canadian Stroke Network. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke","volume":"77","author":"Finlayson","year":"2011","journal-title":"Neurology"},{"key":"B2","first-page":"110","article-title":"Post-stroke infection: a systematic review and meta-analysis","volume-title":"BMC Neurol.","author":"Westendorp","year":"2011"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(14)62456-9","article-title":"The preventative antibiotics in stroke study (PASS): a pragmatic randomised open-label masked endpoint clinical trial","volume":"385","author":"Westendorp","year":"2015","journal-title":"Lancet"},{"key":"B4","first-page":"1225","article-title":"Decision-making in the diagnosis and treatment of stroke-associated pneumonia","volume-title":"J Neurol Neurosurg Psychiatry.","author":"Harms","year":"2012"},{"key":"B5","first-page":"1835","article-title":"on behalf of the STROKE-INF Investigators. prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial","volume-title":"Lancet.","author":"Kalra","year":"2015"},{"key":"B6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrneurol.2012.98","article-title":"The immunology of acute stroke","volume":"8","author":"Chamorro","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"B7","first-page":"867","article-title":"The immune system in stroke: clinical challenges and their translation to experimental research","volume-title":"J Neuroimmune Pharmacol.","author":"Smith","year":"2013"},{"key":"B8","first-page":"89","article-title":"Doxycycline-mediated protective effect against focal cerebral ischemia\u2013reperfusion injury through the modulation of tight junctions and PKC\u03b4 signaling in rats","volume-title":"J Mol Neurosci.","author":"Wang","year":"2012"},{"key":"B9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/STROKEAHA.111.000309","article-title":"Effects of minocycline plus tPA combination therapy after focal embolic stroke in type 1 diabetic rats","volume":"44","author":"Fan","year":"2013","journal-title":"Stroke"},{"key":"B10","first-page":"87","article-title":"The effects of ceftriaxone on skill learning and motor functional outcome after ischemic cortical damage in rats","volume-title":"Restor Neurol Neurosci.","author":"Kim","year":"2013"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12974-015-0245-4","article-title":"Attenuation of acute stroke injury in rat brain by minocycline promotes blood\u2013brain barrier remodeling and alternative microglia\/macrophage activation during recovery","volume":"12","author":"Yang","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B12","first-page":"116","article-title":"Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype","volume-title":"Exp Neurol.","author":"Amantea","year":"2016"},{"key":"B13","first-page":"295","article-title":"The contribution of antibiotics, pneumonia and the immune response to stroke outcome","volume-title":"J Neuroimmunol.","author":"Becker","year":"2016"},{"key":"B14","first-page":"275","article-title":"Neuroprotective effects of erythromycin on ischemic injury following permanent focal cerebral ischemia in rats","volume-title":"Neurol Res.","author":"Katayama","year":"2016"},{"key":"B15","first-page":"1495","article-title":"The early systemic prophylaxis of infection after stroke study. a randomized clinical trial","volume-title":"Stroke.","author":"Chamorro","year":"2005"},{"key":"B16","first-page":"e2158","article-title":"Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial","volume-title":"PLoS ONE.","author":"Harms","year":"2008"},{"key":"B17","first-page":"1220","article-title":"Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after acute ischemic stroke. the mannheim infection in stroke study (MISS)","volume-title":"Stroke.","author":"Schwarz","year":"2008"},{"key":"B18","first-page":"672","article-title":"Preventive antibiotics for stroke-associated pneumonia","volume-title":"Nat Rev Neurol.","author":"Meisel","year":"2015"},{"key":"B19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/STROKEAHA.112.668277","article-title":"Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials","volume":"44","author":"N\u00ed","year":"2013","journal-title":"Stroke"},{"key":"B20","first-page":"689","article-title":"Effect of statin treatment on three-month outcomes in patients with stroke-associated infection: a prospective cohort study","volume-title":"Eur J Neurol.","author":"Yeh","year":"2012"},{"key":"B21","first-page":"61","article-title":"Reduced risk of poststroke pneumonia in thrombolyzed stroke patients with continued statin treatment","volume-title":"Int J Stroke.","author":"Scheitz","year":"2015"},{"key":"B22","first-page":"2360","article-title":"Statin medication use and nosocomial infection risk in the acute phase of stroke","volume-title":"J Stroke Cerebrovasc Dis.","author":"Weeks","year":"2016"},{"key":"B23","first-page":"5642704","article-title":"Effect of prior atorvastatin treatment on the frequency of hospital acquired pneumonia and evolution of biomarkers in patients with acute ischemic stroke: A multicenter prospective study","volume-title":"Biomed Res Int.","author":"Yu","year":"2017"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/STROKEAHA.114.007843","article-title":"How is pneumonia diagnosed in clinical stroke research? a systematic review and meta-analysis","volume":"46","author":"Kishore","year":"2015","journal-title":"Stroke"},{"key":"B25","first-page":"402","article-title":"Prevalence and predictive factors of urinary tract infection among patients with stroke: a meta-analysis","volume-title":"Am J Infect Control.","author":"Yan","year":"2018"},{"key":"B26","first-page":"651","article-title":"Aspiration pneumonia","volume-title":"N Engl J Med.","author":"Mandell","year":"2019"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1161\/STROKEAHA.117.020250","article-title":"Microbiological etiologies of pneumonia complicating stroke: a systematic review","volume":"49","author":"Kishore","year":"2018","journal-title":"Stroke"},{"key":"B28","first-page":"3033","article-title":"Beneficial effect of adjunctive azithromycin in treatment of mucoid Pseudomonas aeruginosa pneumonia in the murine model","volume-title":"Antimicrob Agents Chemother.","author":"Nicolau","year":"1999"},{"key":"B29","first-page":"1193","article-title":"Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: a systematic review and meta-analysis","volume-title":"Respirology.","author":"Horita","year":"2016"},{"key":"B30","first-page":"109","article-title":"Non-anti-infective effects of antimicrobials and their clinical applications: a review","volume-title":"Mayo Clinic Proc.","author":"Sadarangani","year":"2015"},{"key":"B31","first-page":"6146","article-title":"Efficacy of \u03b2-lactam-plus-macrolide combination therapy in a mouse model of lethal pneumococcal pneumonia","volume-title":"Antimicrob Agents Chemother.","author":"Yoshioka","year":"2016"},{"key":"B32","first-page":"298","article-title":"Neuroprotective properties of a macrolide antibiotic in a mouse model of middle cerebral artery occlusion: characterization of the immunomodulatory effects and validation of the efficacy of intravenous administration","volume-title":"Assay Drug Dev Technol.","author":"Amantea","year":"2016"},{"key":"B33","first-page":"7","article-title":"Neuroprotective effects of clarithromycin against neuronal damage in cerebral ischemia and in cultured neuronal cells after oxygen-glucose deprivation","volume-title":"Life Sci.","author":"Katayama","year":"2017"},{"key":"B34","first-page":"518","article-title":"Poly(ADP-ribose) polymerase is not involved in the neuroprotection exerted by azithromycin against ischemic stroke in mice","volume-title":"Eur J Pharmacol.","author":"Petrelli","year":"2016"},{"key":"B35","first-page":"2426","article-title":"The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke","volume-title":"J Hypertens.","author":"Th\u00f6ne-Reineke","year":"2008"},{"key":"B36","first-page":"2287","article-title":"Effect of antibiotic class on stroke outcome","volume-title":"Stroke.","author":"Zierath","year":"2015"},{"key":"B37","first-page":"858","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infection","volume-title":"Clin Microbiol Rev.","author":"Nau","year":"2010"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00504\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T07:41:11Z","timestamp":1557819671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00504\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":37,"alternative-id":["10.3389\/fneur.2019.00504"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00504","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"article-number":"504"}}